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Abstract
Background: The Accu-Chek Inform glucose monitor
is a point-of-care system for testing blood glucose.
New test strips, calibrated to deliver glucose plasma-
like values, were launched on the market in May 2005.
The aim of our study was to perform analytical vali-
dation of these new strips.
Methods: We compared the new plasma strips with
whole blood strips; results for the plasma strips with
plasma values obtained using a clinical analyzer and
with whole blood values given by the glucose elec-
trode of a blood gas analyzer; and the influence of the
type of blood (capillary or venous) on the results
obtained by the glucose monitor with the plasma cal-
ibrated strips.
Results: Plasma strips give on average 7% higher
results than the previous whole blood strips. Howev-
er, the results given by the plasma strips on capillary
whole blood, even if well correlated, are not com-
pletely comparable with those given by an analyzer
for venous plasma. Nevertheless, these plasma strips
and the glucose electrode of a blood gas analyzer give
comparable results.
Conclusions: Accu-Chek Inform plasma strips are a
good method for monitoring of blood glucose values
in patients with diabetes.
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Introduction
The Accu-Chek Inform glucose monitor is a point-of-
care system for testing blood glucose (glucose dehy-
drogenase method, amperometric detection) that can
be used by professionals in healthcare facilities.
Since December 2004 our hospital has used Accu-
Chek Inform monitors, which are distributed in all
wards of the hospital. The glucose results are sent via
our network to the software DataCarePOC (Roche)
and on to our laboratory information system (LIS).
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Harmonization of the reporting of glucose concen-
trations is essential. Indeed, clinical staff generally do
not know whether the laboratory reports blood or
plasma glucose. The International Federation of Clin-
ical Chemistry and Laboratory Medicine (IFCC) advis-
es expression of the concentration of glucose in
plasma rather than in whole blood, regardless of the
sample type and technology. Moreover, the American
Diabetes Association provides clinical decision limits
for the concentration of glucose in plasma.
The IFCC recommends a constant factor of 1.11 to
convert measured glucose concentrations in whole
blood to the equivalent concentrations in plasma (1).
However, this converted result equals the concentra-
tion of glucose in plasma only when hematocrit and
water concentrations are normal.
Considering these observations, in May 2005 Roche
launched new test strips calibrated to deliver glucose
plasma-like values. They established a conversion
factor of 1.08, supposed to be more applicable to any
patient.
We decided to validate the plasma strips before
their use in the wards. In complement of repeatability
and reproducibility, we compared: the new plasma
strips with the whole blood strips; the results of the
plasma strips with the plasma values obtained using
a clinical analyzer and with the whole blood values
given by the glucose electrode of a blood gas analyz-
er; and the influence of the type of blood (capillary or
venous) on the results obtained by the glucose mon-
itor with the plasma calibrated strips.
Materials and methods
We decided to use the same Accu-Chek Inform monitor for
all validation testing to avoid potential variations between
instruments.
The first step of our validation was to compare results
given by the plasma strips with those given by the former
whole blood strips. For this purpose, we collected 60 sam-
ples of venous whole blood in EDTA tubes: 20 fresh samples
were used to obtain normal glucose levels (3.3–5.5 mmol/L),
20 one-day-old samples to obtain low glucose levels
(-3.3 mmol/L) and 20 samples from diabetic patients for
high glucose levels ()11 mmol/L). A drop of blood from
each sample was first applied to the plasma strip and then
to the whole blood strip.
In addition, we took blood samples from ten premature
babies and analyzed them using the plasma and whole blood
strips to investigate whether a high hematocrit level influ-
ences the glycemia results.
To ensure that the results given by the plasma strips coin-
cided with real plasma glycemia, we compared them with
those given by an analyzer (Integra 700; Roche, Mannheim,
Germany, hexokinase method) for plasma. From 54 hospi-
talized patients we simultaneously collected a drop of cap-
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Table 1 Correlation and significant differences between results given by the plasma (PL) and whole blood (WB) strips in
each group of samples.












0.9732 0.9876 0.9262 0.9880 0.9965
PL and WB strips
PL strips
Mean, mmol/L 4.12 15.03 2.06 4.47 6.67
SD, mmol/L 0.53 5.45 0.85 1.40 6.10
CV, % 12.92 36.26 41.30 31.30 91.56
WB strips
Mean, mmol/L 3.77 14.07 1.96 4.09 6.21
SD, mmol/L 0.57 4.87 0.84 1.16 5.67
CV, % 15.05 34.62 42.71 28.37 91.30
Difference
between
p-0.0001 ps0.0001 p)0.05 p-0.01 p-0.0001
PL and WB strips
Figure 1 Comparison between the results given by the
Accu-Chek Inform plasma calibrated strips and the Accu-
Chek Inform whole blood strips.
illary whole blood by puncture and a fluoride tube of venous
whole blood. The capillary whole blood was directly ana-
lyzed by the Accu-Chek Inform monitor using plasma cali-
brated test strips. The fluoride tubes were conserved on ice
and centrifuged within 2 h of collection and glucose was
measured in plasma using the Integra 700.
We also compared the results of the plasma strips with
those given by a blood gas analyzer (Rapidlab 865, Bayer,
Tarrytown, NY, USA; glucose oxidase method, amperome-
tric detection) since the Intensive Care Unit (ICU) uses these
two instruments interchangeably.
A total of 20 syringes of whole blood (11 arterial and 9
venous) were drawn in the ICU. The syringe was first used
for the determination of glycemia using the glucose elec-
trode of a blood gas analyzer. Glucose was immediately
measured in a drop of blood from the same syringe on the
Accu-Chek Inform monitor using a plasma calibrated test
strip.
Finally, we investigated whether samples of capillary and
venous whole blood gave the same glucose results using the
Accu-Chek Inform plasma strips. For this purpose, we simul-
taneously collected a drop of capillary whole blood by punc-
ture and an EDTA tube of venous whole blood from 20
hospitalized patients. The capillary whole blood was directly
analyzed by the Accu-Chek Inform with the plasma calibrated
test strips, followed by a blood drop from the EDTA tube.
Statistics
We used Spearman correlation, the Wilcoxon test, the Mann-
Whitney U-test and Bland-Altman plots for our statistical cal-
culations using Medcalc software (Mariakerke, Belgium).
Results
The repeatability, performed on low- and high-level
controls provided by Roche (laboratory means 3 and
18 mmol/L), gave coefficients of variation of 3.03%
and 3.22%, respectively. For reproducibility, coeffi-
cients of variation of 5.26% and 2.99%, respectively,
were obtained for the same materials.
Comparison between the plasma and whole blood
strips was conducted using 70 samples (60 with nor-
mal, low and high glucose concentration level and 10
with high hematocrit).
We observed a significant difference between the
results obtained with the plasma and the whole blood
strips for the 70 samples (p-0.0001) except for the
low concentration samples (Table 1).
The results of the plasma strips were on average
7% higher than those given by the whole blood strips
(Figure 1). The correlation was excellent in every case.
There was a statistically significant difference
between the results given by the Accu-Chek Inform
and the Integra 700 (p-0.05, ns54). The results of the
Accu-Chek Inform were mainly higher than those
given by the Integra 700, ranging from y3% to 24%
(Figure 2). The correlation was good (rs0.9780).
For the 20 samples drawn in the ICU, there was no
significant difference between the results given by the
blood gas analyzer and those given by the Accu-Chek
Inform, regardless of whether arterial blood or
venous blood samples were used (p)0.05). We
observed good correlation between the methods
(rs0.9778).
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Figure 2 Comparison between the results given by the
Accu-Chek Inform plasma strips and the clinical analyzer
(Integra 700).
There was no significant difference between glu-
cose measured in capillary whole blood or venous
whole blood with the plasma calibrated Accu-Chek
test strips (p)0.05). The correlation was good
(rs0.9615).
Discussion
It is well known that blood glucose measurements
using reagent strip tests vary inversely with increas-
ing sample hematocrit (2, 3). The new Accu-Chek
Inform plasma calibrated strips have been designed
to give plasma-like glucose values independent of the
hematocrit level.
Our first comparisons confirm this observation,
since the difference observed between the results
given by the plasma strips and those given by the
whole blood strips was 7% on average for each group
we studied, including samples with high hematocrit.
This led us to conclude that neither the hematocrit
level nor the glucose concentration influences the dif-
ference between the plasma strips and the whole
blood strips.
We observed a statistical difference between the
results given by the Accu-Chek Inform on capillary
whole blood with the plasma strips and those given
by the Integra 700 on venous plasma. We first thought
that this difference depended on the puncture site.
Indeed, studies (4) have reported that as well as
matrix effects (normally corrected by the plasma cal-
ibrated test strips), physiological mechanisms such as
non-fasting conditions can lead to different glucose
levels in capillary and venous blood. However, we
showed that there was no statistical difference
between glucose measured in capillary whole blood
and venous whole blood with the Accu-Chek Inform
plasma strips.
The second possibility to explain the higher glucose
results given by the Accu-Chek Inform compared to
the Integra results for venous plasma was the delay
before centrifugation (5). Indeed, NaF, even if fluoride
tubes are conserved on ice, has no effect during the
first hour, but begins to slow down glycolysis by the
second hour, inhibiting it more or less completely by
the fourth hour. This could explain the lower results
observed with the Integra analyzer. The decrease in
glucose concentration in fluoride tubes is unfortu-
nately very variable from one patient to another,
explaining why the correction factor applied to the
plasma strips did not lead to results comparable to
those given by an analyzer for plasma sample.
There was no statistical difference between results
given by the plasma strips and those given by a blood
gas analyzer. The puncture site here was the same,
which is not the case in reality. Our study also
showed that the Accu-Chek Inform plasma strips gave
comparable results for capillary and venous whole
blood. We can thus conclude that the Accu-Chek
Inform glucose monitor with plasma strips gives com-
parable glucose results to the glucose electrode of a
blood gas analyzer. This is an important finding, par-
ticularly for the ICU, where physicians interchangea-
bly use the glucose monitor or a blood gas analyzer
for glucose monitoring of patients.
There was good correlation between the Accu-Chek
Inform results for capillary whole blood and the clin-
ical analyzer results for plasma. The Accu-Chek
Inform plasma strips represent a good system for the
monitoring of diabetic patients, particularly in the
ICU, where physicians can use either the Accu-Chek
Inform monitor or a blood gas analyzer.
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